Search Results

0 results for 'Celgene'

You can use to get even better search results
October 01, 2024 | New York Law Journal

Bristol Myers Squibb Wins Dismissal of $6.4 Billion Lawsuit Alleging Intentional Delay of Cancer Drug

U.S. District Judge Jesse Furman dismissed the action, finding plaintiff was never properly appointed as successor-trustee and therefore was unable to bring the suit on behalf of shareholders.
3 minute read
September 06, 2024 | New York Law Journal

Bristol Myers Urges Dismissal of $6.4 Billion Lawsuit, Arguing Lack of Subject Matter Jurisdiction

Bristol Myers Squibb counsel from DLA Piper told U.S. District Court Judge Jesse Furman on Friday that the UMB Bank NA had no standing to sue -- claiming the bank was not properly appointed as successor trustee.
3 minute read
June 14, 2024 | Litigation Daily

Litigators of the Week Runners-Up

Kirkland & Ellis scored a knockout win for Sun Pharmaceutical Industries Ltd. in a more than decadelong multidistrict litigation where the company was accused of conspiring to delay the launch of a generic version of the blockbuster cholesterol drug Lipitor.
7 minute read
October 09, 2023 | The Recorder

Mayo Clinic, Lifepoint Claim Drugmakers Conspired to Delay Generic Competition for Chemo Drug

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read
July 14, 2023 | Litigation Daily

Litigator of the Week Runners-Up and Shout Outs

Runners-up this week include teams from Williams & Connolly, Kramer Levin Naftalis & Frankel, and Singer Cashman.
6 minute read
Law Journal Press | Digital Book State Antitrust Law Authors: William T. Lifland View this Book

View more book results for the query "Celgene"

May 24, 2023 | The American Lawyer

Paul Weiss Adds Former Wachtell Executive Compensation Partner in New York

Andrea Wahlquist Brown has decades of experience at both Wachtell and Simpson Thacher.
3 minute read
November 03, 2022 | New Jersey Law Journal

$763 Per Pill: Lawsuit Accuses Drugmakers of Scheme Involving Cancer Medicine Revlimid

"Defendants' settlement agreement constitutes a horizontal output-restriction and market-allocation agreement—a per se violation of the Sherman Act," the suit says.
3 minute read
September 29, 2022 | Corporate Counsel

'Don't Leave the Junky Work to Somebody Else': A Veteran Legal Chief Shares Leadership Lessons

"I believe firmly in training each person in the legal department to take over from me—to be my successor," said Stephen Kim, chief legal officer of Avicanna.
8 minute read
September 26, 2022 | New York Law Journal

Selendy Gay Elsberg's Newest Name Partners Dig Into the Boutique's One-Office Approach

"Among our partners, we have a very deliberate group of people who have chosen to work together—over the course of decades, in fact," says Jennifer Selendy who was co-managing partner of Selendy Gay Elsberg alongside David Elsberg for the boutique's first four years of existence. They joined Philippe Selendy and Faith Gay as name partners at the beginning of this year.
13 minute read
September 26, 2022 | Litigation Daily

Litigation Leaders: Selendy Gay Elsberg's Newest Name Partners Dig Into the Boutique's One-Office Approach

"Among our partners, we have a very deliberate group of people who have chosen to work together—over the course of decades, in fact," says Jennifer Selendy who was co-managing partner of Selendy Gay Elsberg alongside David Elsberg for the boutique's first four years of existence. They joined Philippe Selendy and Faith Gay as name partners at the beginning of this year.
13 minute read

Resources

  • 2024 Trends Report Mid-Year Special Edition: Update on Outside Counsel Billing Rates

    Brought to you by LexisNexis® CounselLink®

    Download Now

  • AI in Private Equity: A Guide for Gaining an Early Advantage

    Brought to you by Ontra

    Download Now

  • Why Are So Many Law Firms Suddenly Embracing Digital Transformation?

    Brought to you by AllRize

    Download Now

  • 2025 State Legislative Sessions

    Brought to you by LexisNexis®

    Download Now